Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Sep 1;51(5):1014-26.
doi: 10.1016/j.freeradbiomed.2010.11.026. Epub 2010 Dec 1.

Neuroprotective strategies involving ROS in Alzheimer disease

Affiliations
Review

Neuroprotective strategies involving ROS in Alzheimer disease

Magali Dumont et al. Free Radic Biol Med. .

Abstract

Alzheimer disease (AD) is a neurodegenerative disorder in which oxidative stress is a key hallmark. It occurs early in disease pathogenesis and can exacerbate its progression. Several causes of oxidative stress have been determined over the years. First, mitochondria play an important role in the generation and accumulation of free radicals. In addition to mitochondria, inflammation can also induce oxidative damage, especially via microglia, and microglia are also important for Aβ clearance. In AD, both mitochondrial function and inflammatory response are affected, leading to increased ROS formation and oxidative damage to lipid, proteins, and nucleic acids. Some other sources have also been identified. From these findings, various neuroprotective strategies against ROS-mediated damages have been elaborated in AD research. This review recapitulates some of the major strategies used to prevent oxidative stress and disease progression. Outcomes from in vitro and in vivo studies using models of AD are encouraging. However, only a few clinical trials have provided positive results in terms of slowing down cognitive decline. Nonetheless, there is still hope for improved compounds that would better target pathways implicated in ROS production. In fact, facilitating the endogenous antioxidant system by modulating transcription has great promise for AD therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Scheme of the generation and role of free radicals in AD
In cells, free radicals can be generated by 2 major sources: mitochondria and NAPDH oxidase. Several key players, such as metals and/or Aβ can exacerbate their production. Once accumulating inside the cells, free radicals can cause lipid, protein, DNA and RNA damage that can exacerbate AD pathogenesis.
Figure 2
Figure 2. Mitochondria and ROS
(A) Scheme of the mitochondrial electron transport chain. Electrons are transferred from complex I (C-I) to complex IV (C-IV), including coenzyme Q10 (Q) and cytochrome c (Cyt c). (B) Scheme of mitochondria-mediated ROS from the complex I (C-I), complex II (C-II), and III (C-III) and from the tricarboxylic acid cycle (TCA). (C) Chemical reactions for the generation of reactive oxygen species (ROS) such as superoxide (O2), hydrogen peroxide (H2O2), reactive nitrogen species (RNS) such as peroxynitrite, and the chemistry of the Fenton reaction, which generates OH radicals.
Figure 3
Figure 3. Chemical structures of antioxidants
Figure 4
Figure 4. NADPH oxidase and production of ROS
The assembly of NADPH oxidase subunits (gp91phox/p22phox) with cytolosic subunits p47phox, p40phox, p67phox and rac results in the active enzyme responsible for the generation of superoxide.
Figure 5
Figure 5. Antioxidant strategies in AD

Similar articles

Cited by

References

    1. Nunomura A, Castellani RJ, Zhu X, Moreira PI, Perry G, Smith MA. Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol. 2006;65:631–641. - PubMed
    1. Coppede F, Migliore L. DNA damage and repair in Alzheimer's disease. Curr Alzheimer Res. 2009;6:36–47. - PubMed
    1. Lovell MA, Markesbery WR. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res. 2007;35:7497–7504. - PMC - PubMed
    1. Lovell MA, Markesbery WR. Oxidatively modified RNA in mild cognitive impairment. Neurobiol Dis. 2008;29:169–175. - PMC - PubMed
    1. Nunomura A, Moreira PI, Takeda A, Smith MA, Perry G. Oxidative RNA damage and neurodegeneration. Curr. Med. Chem. 2007;14:2968–2975. - PubMed

Publication types

MeSH terms